Zhengwu Yang

Zhengwu Yang

Auto-generated profile, based on publicly available information

Zhengwu Yang

Department of Clinical Laboratory The First Affiliated Hospital of Zhengzhou University, and the Key Clinical Laboratory of Henan Province Henan China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2022 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
ZYZhengwu Yang
Zhengwu Yang
JWJunhu Wan
Junhu Wan
LMLiwei Ma
Liwei Ma
ZLZhuofang Li
Zhuofang Li
RYRuotong Yang
Ruotong Yang
MLMing Liang
Ming Liang
Background: Long non‐coding RNA HOXC cluster antisense RNA 1 (HOXC‐AS1) is a novel lncRNA whose cancer‐promoting effect in gastric cancer and nasopharyngeal carcinoma has already been demonstrated. However, its functions in esophageal squamous cell carcinoma (ESCC) remains unknown. LncRNAs can interact with RNA‐binding proteins (RBPs) and affect gene expression levels through post‐transcriptional regulation. Insulin‐like growth factor 2 mRNA‐binding protein 2 (IGF2BP2) is a widely studied RBP, and sirtuin 1 also known as SIRT1 has been reported to be involved in cancer progression.Methods: Establishment of in vivo models, HE and immunohistochemistry staining verified the oncogenic effect of HOXC‐AS1. The interaction relationship between HOXC‐AS1, IGF2BP2 and SIRT1 was verified by RNA pulldown and RNA immunoprecipitation (RIP) assay. Relative expression and stability changes of genes were detected by qPCR and actinomycin D experiments. Finally, the effect of HOXC‐AS1‐IGF2BP2‐SIRT1 axis on ESCC was verified by rescue experiments.Results: HOXC‐AS1 is highly expressed in ESCC cells and plays oncogenic effects in vivo. qPCR showed the positive relationship between HOXC‐AS1 and SIRT1 following HOXC‐AS1 knockdown or overexpression. RNA‐pulldown, mass spectrometry and RIP assay demonstrated that IGF2BP2 is an RBP downstream of HOXC‐AS1. Then, RIP and qPCR showed that IGF2BP2 could bind to SIRT1 mRNA and knockdown IGF2BP2 resulted in decreased SIRT1 mRNA level. Finally, a series of rescue assay showed that the HOXC‐AS1‐IGF2BP2‐SIRT1 axis can affect the function of ESCC.Conclusion: LncRNA HOXC‐AS1 acts as an oncogenic role in ESCC, which impacts ESCC progression by interaction with IGF2BP2 to stabilize SIRT1 expression.